Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.46 USD
−301.23 M USD
1.25 B USD
60.33 M
About ARGENX SE
Sector
CEO
Tim van Hauwermeiren
Headquarters
Amsterdam
Website
Founded
2008
ISIN
NL0010832176
FIGI
BBG008F56K85
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ARGNF is featured.
Frequently Asked Questions
The current price of ARGNF is 525.60 USD — it has increased by 0.07% in the past 24 hours. Watch Argen X NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Argen X NV stocks are traded under the ticker ARGNF.
We've gathered analysts' opinions on Argen X NV future price: according to them, ARGNF price has a max estimate of 766.55 USD and a min estimate of 549.85 USD. Watch ARGNF chart and read a more detailed Argen X NV stock forecast: see what analysts think of Argen X NV and suggest that you do with its stocks.
ARGNF reached its all-time high on Sep 5, 2024 with the price of 540.00 USD, and its all-time low was 10.22 USD and was reached on Apr 30, 2015. View more price dynamics on ARGNF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ARGNF stock is 2.81% volatile and has beta coefficient of 1.34. Track Argen X NV stock price on the chart and check out the list of the most volatile stocks — is Argen X NV there?
Today Argen X NV has the market capitalization of 37.34 B, it has decreased by −0.92% over the last week.
Yes, you can track Argen X NV financials in yearly and quarterly reports right on TradingView.
Argen X NV is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
ARGNF net income for the last half-year is −32.24 M USD, while the previous report showed −175.32 M USD of net income which accounts for 81.61% change. Track more Argen X NV financial stats to get the full picture.
No, ARGNF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 1, 2024, the company has 1.15 K employees. See our rating of the largest employees — is Argen X NV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Argen X NV EBITDA is −281.99 M USD, and current EBITDA margin is −27.70%. See more stats in Argen X NV financial statements.
Like other stocks, ARGNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Argen X NV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Argen X NV technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Argen X NV stock shows the buy signal. See more of Argen X NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.